Hepatitis B surface antigen screening in a nonindigent population.
The recommendation for universal screening of all pregnant women for hepatitis B surface antigen (HBsAg) is based on data from publicly funded hospitals. We retrospectively reviewed screening results of 2,696 mothers who delivered between May 1989 and April 1990. Our population was 85% privately funded. Screening for HBsAg was positive in 0.07%, negative in 80.4% and not done in 19.6%. All positive screens would have been identified by screening only patients with recognized risk factors. We conclude that the sensitivity of identifiable risk factors to detect HBsAg carriers may be high in some populations. We speculate that universal screening in these populations is not cost efficient.
Meyer
M C
MC
Department of Obstetrics and Gynecology, University of Vermont, Burlington.
Mead
P B
PB
Capeless
E L
EL
D002353:Carrier State / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006521:Hepatitis, Chronic; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening / Q000191:economics*; D008489:Medical Indigency; D011247:Pregnancy; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors
D006514:Hepatitis B Surface Antigens